Open label, randomized, pilot study on the activity of olanzapine with or without delayed dexamenthasone versus dexamenthasone alone for the prevention of delayed nausea and vomiting in patients with gynecologic cancers receiving carboplatin and paclitaxel-based chemotherapy and guidline-directed prophylactic anti-emetics.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2018
At a glance
- Drugs Olanzapine (Primary) ; Dexamethasone; Dexamethasone; Dexamethasone; Palonosetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 27 Feb 2018 New trial record